Lisa Bright
Director/Board Member bei ASCENDIS PHARMA A/S
Vermögen: 59 107 $ am 31.03.2024
Profil
Lisa Jane Bright is currently the Chairman at Resolution Therapeutics Ltd.
She also holds the position of Non-Executive Director at Dechra Pharmaceuticals Plc, Independent Director at Ascendis Pharma A, Director at Immedica Pharma AB, Advisor at DRI Capital, Inc., Executive Partner at Syncona Partners LLP, and President-International at Intercept Pharma Europe Ltd.
Her former positions include Vice President at Gilead Sciences, Inc., President-International at Intercept Pharmaceuticals, Inc., VP-Commercial Planning & Operations at GSK Plc, General Manager at Gilead Sciences Ireland UC, and General Manager at Gilead Sciences Ltd.
Ms. Bright completed her undergraduate degree at University College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0,00% | 31.12.2023 | 391 ( 0,00% ) | 59 107 $ | 31.03.2024 |
Aktive Positionen von Lisa Bright
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENDIS PHARMA A/S | Director/Board Member | 01.04.2017 |
| DECHRA PHARMACEUTICALS | Director/Board Member | 01.02.2019 |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Corporate Officer/Principal | 01.07.2016 |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | - |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Consultant / Advisor | - |
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Chairman | - |
Ehemalige bekannte Positionen von Lisa Bright
| Unternehmen | Position | Ende |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2021 |
| Gilead Sciences Ireland UC | Corporate Officer/Principal | 01.11.2014 |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Lisa Bright
| University College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| DECHRA PHARMACEUTICALS | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Private Unternehmen | 7 |
|---|---|
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Distribution Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
| Gilead Sciences Ireland UC | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The private company is based in London, UK and specializes in the distribution of pharmaceutical products. | Distribution Services |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Commercial Services |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Commercial Services |
